The UCLA Prostate Cancer Index: Development, Reliability, and Validity of a Health-Related Quality of Life Measure

Medical Care

Volumn 36, Issue 7, 1998, Pages 1002-1012

  Litwin, Mark S ^a,b,c   Hays, Ron D ^a,c   Fink, Arlene ^a,c   Ganz, Patricia A ^a,c   Leake, Barbara ^a   Brook, Robert H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RAND CORPORATION   (United States)

Author keywords

Medical outcomes; Prostate adenocarcinoma; Quality of life

Indexed keywords

AGED; ARTICLE; CROSS-SECTIONAL STUDY; FACTORIAL ANALYSIS; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MALE; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SOCIOECONOMICS; STANDARD; UNITED STATES;

AGED; CALIFORNIA; CROSS-SECTIONAL STUDIES; FACTOR ANALYSIS, STATISTICAL; FOCUS GROUPS; HEALTH SURVEYS; HUMANS; MALE; PROSTATIC NEOPLASMS; PSYCHOMETRICS; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 0032109544     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199807000-00007     Document Type: Article

References (39)

1. Parker SL, Tong T, Bolden S, Wingo FA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5.
2. Johansson JE, Holmberg L, Johansson S, Bergström R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 1997;277:467.
3. Walsh PC, Brooks JD. The Swedish prostate cancer paradox. JAMA 1997;277:497.
4. Tannock IF. Management of breast and prostate cancer: How does quality of life enter the equation? Oncology 1990;4:149.
5. Albertsen PC, Aaronson NK, Muller MJ, Keller SD, Ware JE. Health-related quality of life among patients with metastatic prostate cancer. Urology 1997;49 207.
6. Cleary PD, Morrissey G, Oster G. Health-related quality of life in patients with advanced prostate cancer: A multinational perspective. Qual Life Res 1995;4:207.
7. da Silva FC, Fossa SD, Aaronson NK, et al. The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853. Eur J Cancer 1996;32A:72.
8. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman A, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: Results from a Medicare survey. Urology 1995;45:1007.
9. Braslis KG, Santa-Cruz C, Brickman AL, Soloway MS. Quality of life 12 months after radical prostatectomy. Brit J Urol 1995;75:48.
10. Krongrad A, Granville LJ, Burke MA, et al. Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol 1997;157:534.
11. World Health Organization. Constitution of the World Health Organization, Basic Documents. Geneva: WHO, 1948.
12. Tulsky DA. An introduction to test theory. Oncology 1990;4:43.
13. Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 1996;5:212.
14. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) instrument. Urology. 1997;50:920.
15. Litwin MS, Hays RD, Fink A, et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129.
16. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989;27:S217.
17. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473.
18. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey: Reliability and validity in a patient population. Med Care 1988;26:724.
19. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993;2:217.
20. Schag CAC, Heinrich RL. Development of a comprehensive quality of life measurement tool: CARES. Oncology 1990;4:135.
21. Ganz PA, Schag CAC, Lee JJ, Sim MS. The CARES: A generic measure of health related quality of life for patients with cancer. Qual Life Res 1992;1:19.
22. Schag CA, Ganz PA, Heinrich RL. Cancer Rehabilitation Evaluation System-short form (CARES-SF). A cancer-specific rehabilitation and quality of life instrument. Cancer 1991;68:1406.
23. Herr HW, Kornblith AB, Ofman U. A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy. Cancer 1993;71(Suppl):1143.
24. Cassileth BR, Soloway MS, Vogelzang NJ, et al. Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. Qual Life Res 1992;1:323.
25. Litwin MS, Fink A, Hays RD, et al. Quality of life in men with prostate cancer: A pilot study. J Urol 1993;149:494A.
26. Stewart AL, Hays RD, Ware JE. Measuring functioning and well-being: The Medical Outcomes Study approach. Durham, NC: Duke University Press, 1992.
27. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of coexistent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement: Comorbidity and outcomes after hip replacement. Med Care 1993;31:141.
28. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297.
29. Hays RD, Hayashi T. Beyond internal consistency reliability: Rationale and user's guide for multitrait scaling analysis program on the microcomputer. Behavior Research Methods, Instruments & Computers 1990;22:167.
30. Ford JK, MacCallum RC, Tait M. The application of exploratory factor analysis in applied psychology: A critical review and analysis. Personnel Psychol 1986;39:291.
31. Rummel RJ. Applied Factor Analysis. Evanston, IL: Northwestern University Press, 1970.
32. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994;151:54.
33. Schag CA, Ganz PA, Wing DS, Sim MS, Lee JJ. Quality of life in adult survivors of lung, colon, and prostate cancer. Qual Life Res 1994;3:127.
34. Ware JE, Kosinski M, Keller SK. SF-36 Physical and Mental Health Summary Scales: A user's manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
35. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619.
36. Nunnally, J. C. Psychometric theory. 2nd ed. New York: McGraw-Hill, 1978.
37. Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE Database: A methodology for clinical practice and research in prostate cancer. Urology 1996;48:773.
38. Lubeck DP, Litwin MS, Henning JM, Carroll PR. Measurement of health-related quality of life in men with prostate cancer: Data from the CaPSURE(database. Qual Life Res 1997;6:385.
39. Krongrad A, Perczek RE, Burke MA, Granville LJ, Lai H, Lai S. Reliability of Spanish translations of selected urological quality of life instruments. J Urol 1997;158:493.